Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2003
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062273A2 Modulator of the notch signalling pathway and use thereof in medical treatment
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof
07/31/2003WO2003062264A2 Functional ligand display
07/31/2003WO2003062173A2 Alanine 2,3- aminomutase
07/31/2003WO2003061831A2 Sampling device and method for the simultaneous, quantifiable determination of infectious germs
07/31/2003WO2003061712A1 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells
07/31/2003WO2003061710A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
07/31/2003WO2003061681A2 Proteins involved in the regulation of energy homeostasis and organelle metabolism
07/31/2003WO2003061589A2 Methods for treating diseases or conditions with peptide constructs
07/31/2003WO2003061583A2 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes
07/31/2003WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003WO2003061573A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
07/31/2003WO2003061564A2 Gene expression profiles in liver disease
07/31/2003WO2003061520A2 Methods of modulating angiogenesis
07/31/2003WO2003061454A2 Automatically detecting cells having nuclear and cytoplasmic densitometric features associated with disease by optical imaging
07/31/2003WO2003061453A2 Device and method for the identification of analytes in bodily fluids
07/31/2003WO2003061386A1 Wt1 antisense oligos for the inhibition of breast cancer
07/31/2003WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003WO2003061363A2 Mutations caused by activation-induced cytidine deaminase
07/31/2003WO2003048381A3 Ethod for screening anti-bacterial agents
07/31/2003WO2003046148A8 Polypeptide quantitation
07/31/2003WO2003044486A3 Early leukemia diagnostics using microsphere arrays
07/31/2003WO2003044178A3 Hybrid oligonucleotide primers for amplification of dna and uses thereof
07/31/2003WO2003041659A3 Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders
07/31/2003WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
07/31/2003WO2003035679A3 Molecules
07/31/2003WO2003034025A3 Methods and reagents for improved cell-based assays
07/31/2003WO2003033149A3 Systems and methods for performing multiple diagnostic tests
07/31/2003WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same
07/31/2003WO2003029484A3 Antimicrobial methods and materials
07/31/2003WO2003027640A3 Polymorphism detection and separation
07/31/2003WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness
07/31/2003WO2003024388A3 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
07/31/2003WO2003020702A9 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003014879A3 System and method for identifying a genetic risk factor for a disease or pathology
07/31/2003WO2003014378A3 Amperometric biosensor in thick film technology
07/31/2003WO2003008642A3 Amplification of nucleic acid fragments using nicking agents
07/31/2003WO2003008630A3 Methods of profiling gene expression, protein or metabolite levels
07/31/2003WO2003008578A3 Reagents and methods for identifying gene targets for treating cancer
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003004607A3 Aggrecanase molecules
07/31/2003WO2002103320A3 Diagnosis and prognosis of breast cancer patients
07/31/2003WO2002103032A3 Catalases, nucleic acids encoding them and methods for making and using them
07/31/2003WO2002101005A3 A g-protein coupled receptor and uses therefor
07/31/2003WO2002099042A3 Cads as modifiers of the p53 pathway and methods of use
07/31/2003WO2002088363A3 Regulation of novel human prolyl 4-hydroxylases
07/31/2003WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
07/31/2003WO2002083931A3 Method for fixing biomolecules onto chemically inert surfaces
07/31/2003WO2002083893A3 Isolation of dna molecules using mercapto-aryl ligands
07/31/2003WO2002072886A3 Complex element micro-array and methods of use
07/31/2003WO2002068579A3 Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
07/31/2003WO2002066677A3 Model of transmissible spongiform encephalopathic (tse) disease
07/31/2003WO2002062836A3 Detection of antibacterial activity in excretory secretory product of adult trichuris suis
07/31/2003WO2002061390A8 Detection of herpes simplex virus
07/31/2003WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen
07/31/2003WO2002042498A3 Dual bead assays including optical biodiscs and methods relating thereto
07/31/2003WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/31/2003WO2002031206A3 Methods and compositions using hybridization assays for detecting infectious agents
07/31/2003WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003WO2002024747A3 Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications
07/31/2003WO2002024056A3 METHODS AND COMPOSITIONS FOR DETECTING CANCERS ASSOCIATED WITH METHYLATION OF hMLH1PROMOTER DNA
07/31/2003WO2002022884A3 Microarrayed organization of transcription factor target genes
07/31/2003WO2002022850A3 Genome arrays utilizing randomly selected nucleic acid fragments
07/31/2003WO2002020847A3 Gene and sequence variation associated with lipid disorder
07/31/2003WO2002018659A3 Method for determining alleles
07/31/2003WO2002018548A3 Tyrosine hydroxylase 5' control elements and uses thereof
07/31/2003WO2002010450A3 Replicable probe array
07/31/2003WO2002004683A3 Method of detecting an increased susceptibility to breast cancer
07/31/2003WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same
07/31/2003WO2001098339A3 Compositions and methods for the therapy and diagnosis of breast cancer
07/31/2003WO2001096612A3 Method of identifying and quantifying specific fungi and bacteria
07/31/2003WO2001094634A3 Methods and devices for multiplexing amplification reactions
07/31/2003WO2001085912A3 Presenilin enhancers
07/31/2003WO2001067369A3 Combinatorial array for nucleic acid analysis
07/31/2003US20030145348 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
07/31/2003US20030145341 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
07/31/2003US20030144799 Regulatory single nucleotide polymorphisms and methods therefor
07/31/2003US20030144500 Mutation detection method
07/31/2003US20030144497 Novel human transferase proteins and polynucleotides encoding the same
07/31/2003US20030144494 Using polypeptide; incubation, calibration drug
07/31/2003US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents
07/31/2003US20030144482 Diagnosis of skin cancer; vaccine
07/31/2003US20030144239 Expression system
07/31/2003US20030144238 Nucleic acids, polypeptides, and methods for modulating apoptosis
07/31/2003US20030144234 Administering a cathepsin modulator or enzyme inhibitor, select from a mRNA or a protein; gene expression inhibition, analgesics
07/31/2003US20030144233 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
07/31/2003US20030144232 Expression system
07/31/2003US20030144226 Drug screening for an antiviral agent, viricides; genetic engineering
07/31/2003US20030144203 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/31/2003US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica)
07/31/2003US20030144188 Androgen regulated nucleic acid molecules and encoded proteins
07/31/2003US20030144176 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
07/31/2003US20030143725 Microarray fabrication techniques and apparatus
07/31/2003US20030143720 High throughput functional genomics
07/31/2003US20030143692 Methods and compositions for modulating integrin-mediated cell-cell interactions
1 ... 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 ... 3003